Centre de Recherche du CHUM
900 rue Saint-Denis
Tour Viger R09.200
H2X 0A9 Montréal, QC
CANADA
Dr. Elsa Gomez obtained her PhD in Life Sciences with a specialty in Virology from the University of Tours (France) in 2021. Her PhD project was done under the supervision of Prof. Philippe Roingeard and Dr. Elodie Beaumont, and it consisted on the optimization of a bivalent HBV-HCV vaccine. Because of her keen interest on vaccine development and understanding how infections/vaccines trigger a protective immunity, she joined Dr. Naglaa Shoukry's laboratory at the Centre de Recherche du CHUM (CRCHUM) as a Postdoctoral fellow in early 2022.
The main topic of her research is the study of immune responses in HCV infection and specifically, the evaluation of the impact of DAA-based treatment on the restoration of T and B cell responses in drug users at high risk of reinfection. When a vaccine against HCV will be available, drug users may be a priority target of vaccination. Thus, outcomes of this project will inform us whether drug users after DAA-mediated cure may be able to develop a protective immunity upon vaccination.
